Oncolytic adenoviruses and the treatment of pancreatic cancer: a review of clinical trials
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource, 1 online resource.
- Language
-
Englisch
- Bibliographic citation
-
Oncolytic adenoviruses and the treatment of pancreatic cancer: a review of clinical trials ; volume:149 ; number:10 ; day:8 ; month:4 ; year:2023 ; pages:8117-8129 ; date:8.2023
Journal of cancer research and clinical oncology ; 149, Heft 10 (8.4.2023), 8117-8129, 8.2023
- Creator
-
Taylor, Isobel P.
Lopez, J. Alejandro
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s00432-023-04735-w
- URN
-
urn:nbn:de:101:1-2023103012505098238290
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 11:03 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Taylor, Isobel P.
- Lopez, J. Alejandro
- SpringerLink (Online service)
Other Objects (12)
Oncolytic viruses and checkpoint inhibitors: combination therapy in clinical trials
Oncolytic Viruses to Treat Ovarian Cancer Patients – a Review of Results From Clinical Trials
A Cellular Automata Model of Oncolytic Virotherapy in Pancreatic Cancer
In vivo characterization of an oncolytic virus for the treatment of pancreatic cancer
Molecular stratification for the optimization of oncolytic virotherapy in pancreatic ductal adenocarcinoma
MicroRNA-sensitive oncolytic measles virus vectors for chemovirotherapy of pancreatic cancer
Durable response rate as an endpoint in cancer immunotherapy: insights from oncolytic virus clinical trials
Fundamentals of clinical trials
Engineering of oncolytic adenoviruses for delivery by mesenchymal stem cells to pancreatic cancer
Engineering of oncolytic adenoviruses for delivery by mesenchymal stem cells to pancreatic cancer
A Phase I clinical trial of EUS-guided intratumoral injection of the oncolytic virus, HF10 for unresectable locally advanced pancreatic cancer
Oncolytic virotherapy of glioblastoma
Oncolytic viruses and checkpoint inhibitors: combination therapy in clinical trials
Oncolytic Viruses to Treat Ovarian Cancer Patients – a Review of Results From Clinical Trials
A Cellular Automata Model of Oncolytic Virotherapy in Pancreatic Cancer
In vivo characterization of an oncolytic virus for the treatment of pancreatic cancer
Molecular stratification for the optimization of oncolytic virotherapy in pancreatic ductal adenocarcinoma
MicroRNA-sensitive oncolytic measles virus vectors for chemovirotherapy of pancreatic cancer
Durable response rate as an endpoint in cancer immunotherapy: insights from oncolytic virus clinical trials
Fundamentals of clinical trials
Engineering of oncolytic adenoviruses for delivery by mesenchymal stem cells to pancreatic cancer
Engineering of oncolytic adenoviruses for delivery by mesenchymal stem cells to pancreatic cancer
A Phase I clinical trial of EUS-guided intratumoral injection of the oncolytic virus, HF10 for unresectable locally advanced pancreatic cancer
Oncolytic virotherapy of glioblastoma
Oncolytic viruses and checkpoint inhibitors: combination therapy in clinical trials
Oncolytic Viruses to Treat Ovarian Cancer Patients – a Review of Results From Clinical Trials
A Cellular Automata Model of Oncolytic Virotherapy in Pancreatic Cancer
In vivo characterization of an oncolytic virus for the treatment of pancreatic cancer
Molecular stratification for the optimization of oncolytic virotherapy in pancreatic ductal adenocarcinoma
MicroRNA-sensitive oncolytic measles virus vectors for chemovirotherapy of pancreatic cancer
Durable response rate as an endpoint in cancer immunotherapy: insights from oncolytic virus clinical trials
Fundamentals of clinical trials
Engineering of oncolytic adenoviruses for delivery by mesenchymal stem cells to pancreatic cancer
Engineering of oncolytic adenoviruses for delivery by mesenchymal stem cells to pancreatic cancer
A Phase I clinical trial of EUS-guided intratumoral injection of the oncolytic virus, HF10 for unresectable locally advanced pancreatic cancer